dc.creator | Sass, Hans-Martin | en |
dc.date.accessioned | 2015-05-05T19:06:44Z | en |
dc.date.available | 2015-05-05T19:06:44Z | en |
dc.date.created | 1997-11 | en |
dc.date.issued | 1997-11 | en |
dc.identifier | 10.1111/(ISSN)1525-1594 | en |
dc.identifier.bibliographicCitation | Artificial Organs. 1997 Nov; 21(11): 1217-1221. | en |
dc.identifier.issn | 0160-564X | en |
dc.identifier.uri | http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Moral+Aspects+of+Risk+and+Innovation&title=Artificial+Organs.++&volume=21&issue=11&pages=1217-1221&date=1997&au=Sass,+Hans-Martin | en |
dc.identifier.uri | http://dx.doi.org/10.1111/(ISSN)1525-1594 | en |
dc.identifier.uri | http://hdl.handle.net/10822/756244 | en |
dc.description.abstract | In all areas of technological innovation and application, there are
nontechnical (moral, cultural, religious, political, and regulatory) risk
factors and uncertainties that have to be taken into account if research
design and introduction of new devices and applications are to be successful.
Products and methods will be beneficial to the patient if they meet personal
and cultural expectations. Value assessment of individual patients and of
cultural preferences and obstacles therefore has to be included in complex
technology assessment. Successful recognition and management of moral and
cultural risk factors may require changes in governmental regulation and
research design and the development of risk recognition competence within
professional organizations. | en |
dc.format | Article | en |
dc.language | en | en |
dc.source | BRL:MEDKIE/98043985 | en |
dc.subject | Artificial Organs | en |
dc.subject | Autonomy | en |
dc.subject | Beneficence | en |
dc.subject | Biomedical Technologies | en |
dc.subject | Competence | en |
dc.subject | Cultural Pluralism | en |
dc.subject | Consent | en |
dc.subject | Education | en |
dc.subject | Government | en |
dc.subject | Government Regulation | en |
dc.subject | Health | en |
dc.subject | Health Hazards | en |
dc.subject | Informed Consent | en |
dc.subject | Medical Devices | en |
dc.subject | Methods | en |
dc.subject | Moral Policy | en |
dc.subject | Organizations | en |
dc.subject | Paternalism | en |
dc.subject | Patient Care | en |
dc.subject | Patients | en |
dc.subject | Politics | en |
dc.subject | Professional Organizations | en |
dc.subject | Regulation | en |
dc.subject | Research | en |
dc.subject | Research Design | en |
dc.subject | Risk | en |
dc.subject | Risks and Benefits | en |
dc.subject | Technology | en |
dc.subject | Technology Assessment | en |
dc.subject | Uncertainty | en |
dc.subject | Values | en |
dc.title | Moral Aspects of Risk and Innovation | en |
dc.provenance | Digital citation created by the National Reference Center for Bioethics Literature at Georgetown University for the BIOETHICSLINE database, part of the Kennedy Institute of Ethics' Bioethics Information Retrieval Project funded by the United States National Library of Medicine. | en |
dc.provenance | Digital citation migrated from OpenText LiveLink Discovery Server database named NBIO hosted by the Bioethics Research Library to the DSpace collection BioethicsLine hosted by Georgetown University. | en |